ECM
EMC Capital Management’s Reviva Pharmaceuticals RVPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49K | Buy |
128,415
+500
| +0.4% | +$191 | 0.03% | 253 |
|
|
2025
Q1 | $83K | Buy |
127,915
+83,380
| +187% | +$54.1K | 0.05% | 236 |
|
|
2024
Q4 | $81K | Buy |
44,535
+26,134
| +142% | +$47.5K | 0.05% | 236 |
|
|
2024
Q3 | $638K | Sell |
18,401
-105,514
| -85% | -$3.66M | 0.42% | 24 |
|
|
2024
Q2 | $140K | Hold |
123,915
| – | – | 0.08% | 207 |
|
|
2024
Q1 | $411K | Hold |
123,915
| – | – | 0.25% | 56 |
|
|
2023
Q4 | $638K | Hold |
123,915
| – | – | 0.43% | 20 |
|
|
2023
Q3 | $613K | Buy |
123,915
+115,028
| +1,294% | +$569K | 0.45% | 18 |
|
|
2023
Q2 | $83 | Sell |
8,887
-115,028
| -93% | -$1.07K | 0.06% | 233 |
|
|
2023
Q1 | $517K | Hold |
123,915
| – | – | 0.43% | 17 |
|
|
2022
Q4 | $527K | Buy |
123,915
+68,837
| +125% | +$293K | 0.47% | 15 |
|
|
2022
Q3 | $275K | Hold |
55,078
| – | – | 0.25% | 52 |
|
|
2022
Q2 | $62K | Hold |
55,078
| – | – | 0.05% | 260 |
|
|
2022
Q1 | $135K | Hold |
55,078
| – | – | 0.1% | 187 |
|
|
2021
Q4 | $159K | Sell |
55,078
-20,757
| -27% | -$59.9K | 0.09% | 86 |
|
|
2021
Q3 | $265K | Hold |
75,835
| – | – | 0.15% | 87 |
|
|
2021
Q2 | $257K | Hold |
75,835
| – | – | 0.15% | 93 |
|
|
2021
Q1 | $435K | Buy |
+75,835
| New | +$435K | 0.31% | 77 |
|